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Introduction
Sexuality is an important quality-of-life consideration, 
also in late life (Hyde et al., 2012). Sexual health 
severely decreases with age. For males older than 40 
years, erectile dysfunction (ED) is the most common 
sexual disorder, with a reported prevalence of 61% for 
40- to 69-year-olds and 77% for ≥70-year-olds (Wagle, 
Carrejo, & Tan, 2012). ED is defined as the inability to 
achieve or maintain an erection sufficient for satisfac-
tory sexual performance (NIH Consensus Conference 
on Impotence, 1993), and its etiology is widely accepted 
to be multifactorial in nature, including organic, psy-
chological, and social factors.
Besides vascular or neurogenic causes, hormonal fac-
tors seem to play a major role in the development and 
maintenance of ED (Mola, 2015). Higher levels of testos-
terone (T) and dehydroepiandrosterone (DHEA) as well 
as estradiol (E2) have been reported to be associated with 
better overall sexual function and less ED in different age 
groups (Finkelstein et al., 2013; Luo et al., 2015; 
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Rabijewski, Papierska, Kuczerowski, & Piątkiewicz, 
2015), although there is conflicting literature on the asso-
ciation between E2 and ED (El-Sakka, 2013; O’Connor 
et al., 2011; Vignozzi et al., 2014). A recent study reported 
that changes in T and E2 levels in response to T treatment 
were associated with improvements in sexual activity and 
sexual desire, but not erectile function in older men 
(Cunningham et al., 2016). Only a small number of stud-
ies have investigated the association between progester-
one (P), a precursor of the primary sex hormones, and 
ED. Animal models suggest P to be a protective factor 
against ED (Andersen et al., 2007; Shirai et al., 2003). By 
contrast, cortisol (C) as well as proinflammatory cyto-
kines such as interleukin-6 (IL6) have been reported to be 
positively associated with ED in healthy males and in 
males with urological problems (Kobori et al., 2009; 
Ückert et al., 2003; Zhao, Wang, Han, Li, & Yao, 2015).
Identified behavioral and psychosocial risk factors for 
ED are smoking, alcohol consumption, anxiety, stress, 
depression, mental illness, and dementia (Cho et al., 
2006; Corona, Rastrelli, Maseroli, Forti, & Maggi, 2013). 
Literature on protective factors against ED is scarce. 
Although the importance of a multidisciplinary approach 
to the treatment of ED has been emphasized, few studies 
have investigated behavioral and psychosocial protective 
factors against ED (Shabsigh et al., 1998). The most fre-
quently described such factors include exercise, healthy 
diet, good relationship quality, and engaging in sexual 
activity (Cho et al., 2006; Corona et al., 2013). As sexual 
health can be seen as a mirror of men’s overall health 
status (Capogrosso, Montorsi, & Salonia, 2015), protec-
tive factors against health deterioration in aging men 
might, at the same time, be protective factors against age-
related ED. Positive affect, optimism, social and emo-
tional support, relationship quality, and satisfaction with 
life are among the best described factors in this regard 
(Barrett, Putzke, & Richards, 2002; Berry & Worthington, 
2001; Dainese et al., 2011; De Moor et al., 2006; 
Krokavcova et al., 2008).
To assess protective factors against ED, in the current 
study, steroid hormones, a proinflammatory cytokine and 
psychosocial protective factors were examined in parallel 
with regard to their association with ED and their modify-
ing effect on the cross-sectional association between age 
and ED.
Material and Method
Participants
This study was part of the Men’s Health 40+ study (Walther, 
Philipp, Lozza, & Ehlert, 2016). The sample of the present 
study consisted of 271 self-reporting healthy men aged 40 
to 75 years. Participants provided information about their 
current health status and medication intake via standard-
ized questionnaires. Table 1 presents specific sample char-
acteristics. Participants provided psychometric data on 
sexual health and psychosocial protective factors and 
endocrine and proinflammatory parameters. Informed con-
sent was obtained from all participants before completing 
the measures. The local Ethics Committee of the Faculty of 
Arts at the University of Zurich approved the study proto-
col before data collection.
Erectile Dysfunction
The status of ED was assessed with the International 
Index of Erectile Function (IIEF), a self-report measure 
that is well validated and widely used in clinical and epi-
demiological studies (Rosen, Wagner, & Riley, 1997). 
The German version of the IIEF was applied, for which 
the authors suggest calculating a main scale including all 
15 items, a scale for sexual desire consisting of 3 items 
(IIEF-SD), and a scale for sexual function (IIEF-SF)—
mainly reflecting erectile function—consisting of 
12 items (Wiltink et al., 2003). A main score lower than 
53 is considered as a clinically relevant cutoff for ED, 
indicating at least a mild ED. For the scale used to assess 
sexual function, the internal consistency was satisfactory, 
with Cronbach’s alpha of .82. Participants also responded 
to additional questions related to sexual health derived 
from the questionnaire of the European Male Aging 
Study, addressing the frequency of sexual thoughts, the 
frequency of sexual intercourse, the frequency of mastur-
bating, the frequency of having woken up with an erec-
tion, the decrease in having woken up with an erection, 
whether the amount of sexual intercourse was satisfying, 
and whether sexual desire has changed, all referring to 
the past year (O’Connor et al., 2008).
Psychosocial Protective Factors
Psychosocial protective factors were assessed via self-
report measures. Well-validated psychometric instru-
ments were completed for perceived general health 
(SF-36-PGH; Ruta, Abdalla, Garratt, Coutts, & Russell, 
1994), emotional support (BSSS-ES; Schulz & Schwarzer, 
2003), relationship quality (RAS; Barrett et al., 2002), 
affiliation and intimacy motivation (GOALS-A/-I; 
Pöhlmann & Brunstein, 1997), optimism (LOT-R; 
Glaesmer, Hoyer, Klotsche, & Herzberg, 2008), resil-
ience (RS-11; Schumacher, Leppert, Gunzelmann, 
Strauß, & Brähler, 2005), and satisfaction with life 
(SWLS; Glaesmer, Grande, Braehler, & Roth, 2011). For 
descriptive information on the psychometric instruments, 
see the appendix. For all psychometric instruments, satis-
factory internal consistency has been reported, with 
Cronbach’s alpha ranging from .72 to .91.
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Salivary Analytes
Saliva samples were obtained in a standardized procedure 
between 8:00 a.m. and 8:15 a.m. Participants were asked 
to successively fill 3 SaliCaps of 2 mL capacity (SaliCaps, 
IBL International GmbH, Hamburg, Germany) with 
saliva. The following parameters were used for the pres-
ent study: T, DHEA, E2, P, C, and IL6.
All saliva samples were stored at −20°C until required 
for biochemical analysis. Salivary analytes were ana-
lyzed either in the biochemical laboratory of the 
Department of Psychology of the University of Zurich or 
in the biochemical laboratory of the Technical University 
of Dresden.
Potential Covariates and Confounders
The included covariates were age, BMI, marital status, 
smoking status and alcohol consumption, medication 
intake, drug consumption, potency medication intake, 
education, and having had a cold or an injury or bleeding 
in the mouth in the past 7 days. Due to occasionally 
occurring delays in participants’ saliva sampling and the 
circadian rhythmicity of different hormones, the exact 
starting time of saliva collection was used as a covariate. 
The current health condition and the amount of hours of 
physical activity per week were further included as 
covariates.
Statistical Analysis
First, outliers were identified and removed for the sali-
vary parameters. Values that were greater or less than 3 
standard deviations around the mean were removed 
(Rousseeuw & Croux, 1993). For T, 1.1% (n = 3); for 
DHEA, 1.8% (n = 5); for E2, 0.4% (n = 1); for P, 2.6% 
(n = 7); for C, 3.3% (n = 9); and for IL6, 0.8% (n = 2) of 
values were removed.
Quantile regressions for sexual function by age were 
computed for the 10% and the 25% quantile of the sam-
ple. To illustrate the risk groups of low levels of sexual 
Table 1. Descriptive Statistics of the Sample for 
Demographic, Sexual Health, and Psychosocial Protective 
Factors.
Total (n = 271)
Age, M (SD) 57.1 (10.7)
Current health condition, n (%)
 Very good 97 (35.8)
 Good 148 (54.6)
 Fair 26 (9.6)
 Bad 0 (0.0)
 Very bad 0 (0.0)
Body mass index, kg/m2, M (SD) 25.4 (3.4)
Education, n (%)
 Tertiary education 106 (39.1)
 Postsecondary nontertiary 
education
57 (21.0)
 Higher secondary school 76 (28.0)
 Lower secondary education 32 (11.1)
 Did not finish regular school 2 (0.8)
Current smoking status, n (%)
 Nonsmoker 224 (82.7)
 Occasional smoker 25 (9.1)
 Smoker 22 (8.2)
Alcohol consumption, n (%)
 Never 56 (20.4)
 1-6 Drinks per week 161 (59.4)
 ≥1 Drinks per day 54 (20.2)
Medication intake, n (%)
 No 180 (66.4)
 Yes 91 (33.6)
Sexual health with the IIEF, M (SD)
 Erectile function 43.3 (16.8)
 Sexual desire 9 (3.0)
Additional sexual health-related questionsa, n (%)
Sexual thoughtsa
  Never 10 (3.7)
  1-3 Times a month 34 (12.6)
  1-6 Times a week 142 (52.4)
  ≥1 Times a day 85 (31.4)
Sexual intercoursea
  Never 68 (25.2)
  1-3 Times a month 103 (38.1)
  1-3 Times a week 91 (33.6)
  >3 Times a week 9 (3.3)
Masturbationa
  Never 30 (11.1)
  1-3 Times a month 111 (41.0)
  1-6 Times a week 120 (44.3)
  ≥1 Times a day 10 (3.7)
Metrics of psychosocial protective factors, M (SD)
 Perceived general health (SF-36-
PGH)
22.9 (2.9)
 Satisfaction with life (SWLS) 27.7 (4.7)
 Resilience (RS-11) 61.1 (8.0)
 Optimism (LOT-R) 17.6 (3.6)
 Emotional support (BSSS-ES) 3.5 (0.5)
 Motivation (GOALS)  
  Affiliation (GOALS-A) 12.1 (3.6)
  Intimacy (GOALS-I) 17.5 (2.4)
Engaged in a romantic relationship, 
n (%)
240 (88.5)
Relationship quality (RAS) 4.2 (0.7)
aAdditional sexual health-related questions were obtained from the 
European Male Aging Study–Sexual Function Questionnaire (Wiltink, 
Hauck, Phädayanon, Weidner, & Beutel, 2003).
(continued)
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Table 3. Partial Correlations for Sexual Health and 
Hormonal and Inflammatory Protective Factors.
1 2 3 4 5 6
1. IIEF-SF  
2. T −.029  
3. DHEA .053 .353**  
4. E2 −.084 .288** .152*  
5. P −.011 .319** .216* .395**  
6. C −.088 .246** .285** .112 .228**  
7. IL6 −.046 .136* .212* .215* .171* .023
Note. IIEF-SF = sexual function; T = testosterone; DHEA = 
dehydroepiandrosterone; E2 = estradiol; P = progesterone; C = 
cortisol; IL6 = interleukin-6. Pearson correlations.
*p < .05. **p < .01.
function, the areas between the regression lines were col-
ored red (0% to 10%), orange (10% to 25%), and green 
(25% to 100%).
Associations between ED, age, salivary analytes, and 
psychosocial protective factors were analyzed using 
Pearson bivariate and partial correlations. To examine 
whether the association between age and ED was influ-
enced by either endocrine and inflammatory markers or 
psychosocial protective factors, moderation analyses 
were conducted according to Hayes (Hayes, 2013). 
Additionally, the potential covariates and confounders 
introduced were included in the analyses. In a next step, 
homogeneous groups of participants were searched for 
using a hierarchical cluster analysis based on the vari-
ables of age and sexual function. Both variables were 
standardized for this analysis to account for their different 
ranges. The Euclidean distance was employed as a mea-
sure of distance in this analysis. In a first step, single-
linkage clustering was used to determine possible outliers. 
Based on a visual inspection of the dendrogram of this 
analysis, one participant was identified as outlier and 
excluded from the further data analysis, reducing the 
sample to 270 participants. In a second step, clusters of 
participants were formed using the Ward method. The 
number of clusters for all subsequent analyses was deter-
mined with Mojena’s test and the elbow method 
(Backhaus, Erichson, Plinke, & Weiber, 2015); both 
methods indicated the presence of four clusters. To com-
pare the different clusters, t tests for independent samples 
were calculated (Backhaus et al., 2015).
Analyses were conducted using R version 3.2.2 (R 
Core Team, 2016) and SPSS 23 (IBM Corp; Statistics). 
The level of significance was set at α = .05.
Results
Demographic, sexual, and psychosocial characteristics of 
the sample consisting of 271 participants are presented in 
Table 1. Table 2 presents descriptive statistics of the sali-
vary analytes. Figure 1 shows quantile regressions for 
sexual function by age.
A score below 53 on the main scale of the IIEF is con-
sidered to indicate a clinically relevant ED (Wiltink et al., 
2003). In the current sample, 34.7% of participants scored 
below this cutoff. Partial correlation analysis identified 
that age was significantly associated with ED (IIEF-SF; 
r = −.272, p = .000). As presented in Table 3, partial cor-
relation analysis identified that ED was neither directly 
associated with steroid hormones nor with IL6 (all 
p > .05). For psychosocial protective factors, positive 
associations emerged for perceived general health 
(SF-36-PGH; r = .119, p = .028), emotional support 
(BSSS-ES; r = −.188, p = .001), relationship quality 
(RAS; r = .305, p = .000), intimacy motivation (GOALS-I; 
r = .170, p = .003), resilience (RS-11; r = .131, p = .018), 
and satisfaction with life (SWLS; r = .282, p = .000; see 
Table 2. Descriptive Statistics of Salivary Analytes (Sex 
Steroids and IL6 Are Depicted in pg/mL and C in nmol/L).
T DHEA E2 P C IL6
Na 268 266 270 264 262 248
M 67.4 256.3 1.32 28.43 18.3 3.9
SD 26.7 224.3 1.0 18.8 8.2 3.4
Minimum 7.8 8.1 0.16 0.05 1.8 0.08
Maximum 165.1 1129.5 6.0 104.2 47.3 17.4
Note. T = testosterone; DHEA = dehydroepiandrosterone;  
E2 = estradiol; P = progesterone; C = cortisol; IL6 = interleukin-6.
aAbsolute number of analyzed hormonal parameters included 
for statistical analyses of 271 included participants. The numbers 
vary slightly among different salivary analytes due to exclusion of 
extreme values. A total of 21 participants had IL6 levels below the 
detection range.
Figure 1. Quantile regressions for sexual function by age for 
the 10% and the 25% quantile of the sample.
Note. IIEF-SF = Sexual Function.
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Table 4). No associations between hormonal or inflam-
matory parameters and psychosocial variables were iden-
tified after inclusion of confounders.
Moderation effects of protective factors on the rela-
tionship between age and ED were analyzed with modera-
tion analyses according to Hayes by including the 
introduced confounders. Moderation analyses for the 
endocrine and inflammatory parameters identified signifi-
cant associations between age and ED for T (β = .0076, 
p = .035, f 2 = .0178), DHEA (β = .001, p = .007, f 2 = 
.029), and IL6 (β = −.0614, p = .039, f 2 = .0184; see Figure 
2). Further moderation analyses for E2, P, and C failed to 
reach statistical significance (see the appendix). 
Moderation analyses for the psychosocial parameters 
identified significant associations between age and ED for 
perceived general health (β = .0928, p = .004, f 2 = .0328), 
emotional support (β = .4321, p = .017, f 2 = .0228), and 
intimacy motivation (β = .1129, p = .003, f 2 = .0351; see 
Figure 2), while for relationship quality, affiliation moti-
vation, optimism, resilience, and satisfaction with life, 
moderation analyses did not reach statistical significance 
(see the appendix).
As presented in Figure 3, a hierarchical cluster analy-
sis using the Ward method for sexual function by age 
identified four clusters (middle-aged men with [n = 31] 
and without ED [n = 77] and older men with [n = 70] and 
without ED [n = 92]). The subsequently computed group 
comparisons using t tests revealed group differences 
between older men with and without ED for T (t = 2.078, 
p = .039, d = .34), and DHEA (t = 3.864, p = .000, 
d = .64), but not for E2, P, C, or IL6. With regard to psy-
chometric measures, group differences were reported for 
constructs such as perceived general health (t = 3.980, 
p = .000, d = .63), emotional support (t = 3.340, p = .001, 
d = .53), intimacy motivation (t = 3.264, p = .001, d = .53), 
satisfaction with life (t = 3.308, p = .001, d = .52), 
resilience (t = 2.068, p = .040, d = .33), and relationship 
quality (t = 3.064, p = .003, d = .51). No differences 
emerged for optimism and affiliation motivation. Taken 
together, older men without ED, in comparison with older 
men with ED, exhibited higher T and DHEA levels and 
reported higher perceived general health, emotional sup-
port, intimacy motivation, satisfaction with life, and resil-
ience, and a better relationship quality.
No group differences between middle-aged men with 
and without ED emerged for sex steroids, or for C or 
IL6. The only psychometric construct that differed sig-
nificantly between the two groups was satisfaction with 
life (t = 2.755, p = .009, d = .66), indicating more satis-
faction with life in middle-aged men without ED. 
However, relationship satisfaction reached a statistical 
trend (t = 1.751, p = .096, d = .54), indicating higher 
relationship satisfaction in middle-aged men without 
ED. Further analyses of group differences are reported 
in the appendix.
Discussion
In this sample of self-reporting healthy men aged between 
40 and 75 years, 34.7% reported at least a mild form of ED. 
Neither steroid hormones nor the proinflammatory marker 
IL6 were directly associated with ED. However, ED was 
negatively associated with perceived general health, emo-
tional support, intimacy motivation, relationship quality, 
resilience, and satisfaction with life, but not with affiliation 
motivation and optimism. Both endocrine and psychoso-
cial parameters modified the association between age and 
ED. Higher T and DHEA and lower IL6 levels buffered the 
association between age and ED. A buffering effect on the 
cross-sectional age-related increase in ED was also 
revealed for higher perceived general health, emotional 
support, and intimacy motivation. Furthermore, a hierar-
chical cluster analysis on age and sexual function indicated 
four clusters, representing middle-aged men with and 
Table 4. Partial Correlations for Sexual Health and Psychological Protective Factors.
1 2 3 4 5 6 7 8
1. IIEF-SF  
2. SF-36-PGH .119*  
3. BSSS-ES .188** .107  
4. RAS .305** .099 .397**  
5. GOALS-A .054 .063 .215* .002  
6. GOALS-I .170** .155* .391** .106 .335**  
7. LOT-R .097 .264** .282** .270** .049 .175*  
8. RS-11 .131** .266** .347** .241** .217** .326** .526**  
9. SWLS .282** .214* .263** .483** −.057 .097 .540** .386**
Note. IIEF-SF = sexual function; SF-36-PGH = perceived general health; BSSS-ES = emotional support; RAS = relationship quality; 
GOALS-A = affiliation motivation; GOALS-I = intimacy motivation; LOT-R = optimism; RS-11 = resilience; SWLS = satisfaction with life. Number 
of participants vary slightly among different variables. Pearson correlations controlled for confounders.
*p < .05. **p < .01.
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without ED and older men with and without ED. This find-
ing raises the question of potentially different forms of ED 
in these age groups. Group differences in sex steroid levels 
with regard to ED status were present in older men but not 
in middle-aged men. Furthermore, several psychosocial 
protective factors differed between older men with and 
without ED, while in middle-aged men only satisfaction 
with life was significantly higher in those men without ED. 
Besides higher sex steroid levels, for middle-aged men 
with ED, higher intimacy motivation and a trend toward 
more emotional support than in older men with ED was 
also reported. This indicates an age-related loss of intimacy 
motivation and potentially emotional support in men suf-
fering from ED. In addition, older men with ED differed 
from middle-aged men without ED not only with regard to 
sex steroids but also in C and IL6 levels suggesting an 
ED-related increase in C and IL6 levels from middle-aged 
to older men (see the appendix).
Age is the most influential risk factor for ED. In the 
current sample of self-reporting healthy men, ED was 
Figure 2. Moderation plots for psychobiological protective factors on the association between age and erectile dysfunction.
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present in 34.7% and demonstrated a strong cross-sectional 
increase with age. Therefore, the identification of protec-
tive factors decelerating the age-related increase in ED is 
of major interest for men’s sexual health. The findings are 
in accordance with previous research reporting that higher 
endogenous levels of T and DHEA are beneficially related 
to sexual health in men and seem to decelerate the age-
related increase in ED (Walther & Ehlert, 2015). As ED is 
often related to vasculogenic disturbances, T and DHEA 
might exert their beneficial effects on ED via their vasodi-
lative properties. Furthermore, lower levels of IL6 were 
associated with a buffered age-related increase in symp-
toms of ED, which further confirms the hypothesis of an 
association between inflammation and ED. The levels of a 
number of proinflammatory cytokines are also elevated in 
heart failure or heart dysfunction, and the administration of 
potency medication such as sildenafil was reported to 
cause a sustained reduction of proinflammatory cytokines, 
linking the influence of proinflammatory cytokines on vas-
culogenic function and ED (Zhao et al., 2015).
As middle-aged men’s ED is assumed to differ from 
older men’s ED (Mola, 2015), there is a need for tailored 
treatment approaches. In the present sample, the com-
puted cluster analysis indicates a cutoff at the age of 54.5 
years for a separation between middle-aged and older 
men with ED. While younger than 54.5 years, ED might 
be more associated with psychosocial and lifestyle fac-
tors, age-related biological changes occurring after the 
age of 54.5 years might be responsible for ED in the 
majority of older men. Therefore, for ED prevention in 
older men, and to help target the development of disor-
ders early on, it might be crucial to begin monitoring 
endocrine and inflammatory levels, and neurogenic or 
anatomic function, at the age of 54.5 years.
Calculated effect sizes for the moderating effects of 
endocrine, inflammatory, or psychosocial protective fac-
tors on the age-related increase in ED were in general 
medium to large, indicating a similar level of influence of 
biological and psychosocial factors on the age-related 
increase in ED. These results further add and contribute to 
previous research reporting that directly after age, modifi-
able lifestyle factors and comorbidities are the most impor-
tant contributors to the development of ED (Kupelian, 
Araujo, Chiu, Rosen, & McKinlay, 2010). The relatedness 
of biological, psychosocial, and lifestyle factors in terms of 
the age-related increase in ED seems to be best explained 
by their concomitant influence on general health, which in 
turn is reflected by erectile function (Capogrosso et al., 
2015). This is supported by the present results, which indi-
cate that perceived general health, as a proxy of general 
health, is associated with a buffered age-related increase in 
ED. However, lifestyle and psychosocial interventions are 
discussed to have beneficial effects on endothelial function 
and nitric oxide bioavailability, indicating that glycometa-
bolic disorder is involved in the underlying pathophysiol-
ogy of organic ED (Capogrosso et al., 2015; Chitaley, 
Kupelian, Subak, & Wessells, 2009). Furthermore, weight 
loss, causing a decrease in inflammation and an increase in 
T levels, has also been mentioned as possible mechanism 
through which erectile function could be reestablished 
(Lamina, Okoye, & Dagogo, 2009).
There are several limitations that need to be taken into 
consideration when interpreting the results. The cross-
sectional design of the study does not allow causal con-
clusions, and further longitudinal examinations need to 
be carried out to confirm the obtained between-subject 
results using within-subject designs. A further limitation 
is the small sample size, which limits the statistical power 
and interpretation of the data. Apart from the self-report 
measurement of erectile function, there was no examina-
tion of ED by a clinician. Future studies should combine 
self-report measurements and clinical examination to 
ensure high sensitivity and specificity of ED diagnosis. A 
final limitation is that the results only apply to self-report-
ing healthy men aged between 40 and 75 years. As ED 
has been strongly related to general health and vascular 
disorders (Mola, 2015), the described sample might rep-
resent a less vulnerable sample to ED than the general 
population.
Conclusion
Studies attempting to determine the factors that lead to ED 
have been able to formulate numerous risk factors for ED, 
but efficient prevention and treatment strategies integrat-
ing endocrine, inflammatory and psychosocial protective 
Figure 3. Hierarchical cluster analysis for sexual function by 
age.
Note. ED = erectile dysfunction. Black filled circles represent Cluster 
1 = middle-aged men without ED. Black empty circles represent 
Cluster 2 = middle-aged men with ED. Black filled triangles represent 
Cluster 3 = older men without ED. Black empty triangles represent 
Cluster 4 = older men with ED.
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factors for prevention, and early targeting of the very com-
mon disorder remain elusive. Combating the age-related 
increase in ED requires a combined intervention strategy 
consisting of androgen supplementation, anti-inflamma-
tory interventions, diabetes and hypertension control in 
older males, alongside psychosocial interventions to 
improve emotional support, intimacy motivation, relation-
ship quality, and satisfaction with life, as well as healthy 
lifestyle interventions addressing physical activity, smok-
ing, and alcohol consumption both in middle-aged and 
older males.
Appendix
Psychosocial Protective Factors
To measure participants’ satisfaction in an intimate rela-
tionship or marriage the RAS was used, consisting of 
seven Likert-type items, for which satisfactory reliability 
and validity were reported (Sander & Böcker, 1993). In 
this study, Cronbach’s alpha of .91 was reported.
The motivational questionnaire (GOALS) evaluates the 
six domains: power, achievement, diversification, altru-
ism, intimacy (GOALS-I), and affiliation (GOALS-A). 
Cronbach’s alpha for the two domains used in our study 
(intimacy and affiliation) were .70 and .90 (Pöhlmann & 
Brunstein, 1997).
For evaluating optimism in participants, the German 
version of the Life-Orientation-Test (LOT-R) was used, 
that consists of 10 items on a 5-point Likert-type scale; 3 
are optimistic formulated, 3 are pessimistic formulated, 
and 4 are neutral formulated. The LOT-R reaches 
Cronbach’s alpha of .92 (Glaesmer et al., 2008). 
Cronbach’s alpha in this study was .71.
To measure the resilience of participants, the German 
version of the resilience scale was used. It contains 11 
one-dimensional items and shows Cronbach’s alpha of 
.91 (Schumacher et al., 2005). In this study, Cronbach’s 
alpha of .84 was reported.
To evaluate life satisfaction, the Satisfaction with Life 
Scale (SWLS) with five items on a 7-point Likert-type 
scale was used. The SWLS reaches Cronbach’s alpha of 
.92 (Glaesmer et al., 2011). In this study, Cronbach’s 
alpha of .89 was reported.
The Short Form (SF-36) was used to evaluate the par-
ticipants’ perceived general health by 36 self-adminis-
trated items. The multi-item Likert-type scale assess eight 
health concepts including general health perception 
(SF-36-PGH) with a reported Cronbach’s alpha higher 
than .80 (Jenkinson, Coulter, & Wright, 1993).
The Berlin Social Support Scales (BSSS) were used 
to assess participants’ emotional (BSSS-ES), instrumen-
tal (BSSS-IS), and total social support (BSSS). The 
questionnaire consists of 17 items on a 4-point Likert-type 
scale. Cronbach’s alpha for the three BSSS scales ranged 
in this study between .83 and .86 (Schulz & Schwarzer, 
2003).
Results not in Included in the Main Text: 
Further Analyses of Group Differences
Group differences between middle-aged men with ED 
and older men with ED revealed higher levels of T 
(t = −3.114, p = .003, d = .74), DHEA (t = −3.688, p = .001, 
d = .91), and P (t = −2.124, p = .046, d = .46), and a higher 
intimacy motivation (t = −2.523, p = .014, d = .50), 
as well as a trend toward more emotional support 
(t = −1.869, p = .065, d = .41) in middle-aged men with 
ED. Analysis of group differences between middle-aged 
men without ED and older men without ED identified 
higher levels of T (t = −3.114, p = .003, d = .49), DHEA 
(t = −3.688, p = .001, d = .38), and P (t = −2.124, p = .046, 
d = .50) in middle-aged men without ED, and no differ-
ences in psychosocial constructs. Analysis of group dif-
ferences between middle-aged men without ED and older 
men with ED revealed significant differences for all sali-
vary analytes (T: t = 5.020, p = .000, d = .83; DHEA: 
t = 5.579, p = .000, d = .92; E2: t = 2.129, p = .035, d = .35; 
P: t = 3.364, p = .001, d = .56; C: t = −2.151, p = .034, d = .36; 
IL6: t = −2.464, p = .015, d = .42). Taken together, mid-
dle-aged men without ED in comparison with older men 
with ED exhibited higher levels of T, DHEA, E2, and P 
and lower levels of C and IL6. With regard to psychoso-
cial constructs, middle-aged men without ED reported 
higher perceived general health (t = 2.408, p = .017, d = .40) 
emotional support (t = 4.342, p = .000, d = .71), intimacy 
motivation (t = 2.410, p = .017, d = .40), and satisfaction 
with life (t = 2.049, p = .043, d = .34) compared with 
older men with ED.
Additional moderation plots for psychobiological pro-
tective factors on the association between age and ED:
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